↓ Skip to main content

Melanoma inhibitory activity in Brazilian patients with cutaneous melanoma

Overview of attention for article published in Anais Brasileiros de Dermatologia, June 2015
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
9 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Melanoma inhibitory activity in Brazilian patients with cutaneous melanoma
Published in
Anais Brasileiros de Dermatologia, June 2015
DOI 10.1590/abd1806-4841.20153248
Pubmed ID
Authors

Macanori Odashiro, Gunter Hans Filho, Patricia Rusa Pereira, Ana Rita Coimbra Motta Castro, Alcione Cavalheiro Stief, Elenir Rose Jardim Cury Pontes, Alexandre Nakao Odashiro

Abstract

Melanoma inhibitory activity is a protein secreted by melanoma cells and has been used as a tumor marker. Increased Melanoma inhibitory activity serum levels are related to metastatic disease or tumor recurrence. Currently there are no studies on Melanoma inhibitory activity and cutaneous melanoma involving Brazilian patients. To evaluate the performance and feasibility of measuring Melanoma inhibitory activity levels in Brazilian patients with cutaneous melanoma. Blood was obtained from ten patients with proved metastatic cutaneous melanoma (Group 1), 15 patients resected for cutaneous melanoma without metastasis (Group 2) and 5 healthy donors (Group 3). Melanoma inhibitory activity was measured using a commercially available ELISA kit. There was a statistically significant difference of Melanoma inhibitory activity levels between patients with and without metastasis (p=0.002), and between patients with metastasis and healthy donors (p=0.002). There was no difference between patients without metastasis and healthy donors (p=0.443). Melanoma inhibitory activity is a tumor marker for cutaneous melanoma and the Melanoma inhibitory activity-ELISA test can be easily performed. Patients with metastasis have increased Melanoma inhibitory activity serum levels when compared to patients without metastasis and healthy donors.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 9 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 22%
Professor 1 11%
Student > Bachelor 1 11%
Student > Ph. D. Student 1 11%
Student > Doctoral Student 1 11%
Other 1 11%
Unknown 2 22%
Readers by discipline Count As %
Agricultural and Biological Sciences 3 33%
Biochemistry, Genetics and Molecular Biology 1 11%
Pharmacology, Toxicology and Pharmaceutical Science 1 11%
Medicine and Dentistry 1 11%
Unknown 3 33%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 June 2015.
All research outputs
#10,043,954
of 12,554,428 outputs
Outputs from Anais Brasileiros de Dermatologia
#260
of 394 outputs
Outputs of similar age
#159,475
of 232,721 outputs
Outputs of similar age from Anais Brasileiros de Dermatologia
#6
of 6 outputs
Altmetric has tracked 12,554,428 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 394 research outputs from this source. They receive a mean Attention Score of 2.9. This one is in the 19th percentile – i.e., 19% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 232,721 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one.